Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling-Reference-Cited by-同舟云学术

Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling

Published:2021-07-20 Issue:9 Volume:10 Page:1018-1031
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Costales Chester¹,Lin Jian¹,Kimoto Emi¹^ORCID,Yamazaki Shinji²^ORCID,Gosset James R.³,Rodrigues A. David¹,Lazzaro Sarah¹,West Mark A.¹,West Michael⁴,Varma Manthena V. S.¹^ORCID

Affiliation:

1. Pharmacokinetics, Dynamics and Metabolism, Medicine Design Worldwide R&D Pfizer Inc Groton CT USA

2. Pharmacokinetics, Dynamics and Metabolism, Medicine Design Worldwide R&D Pfizer Inc San Diego CA USA

3. Pharmacokinetics, Dynamics and Metabolism, Medicine Design Worldwide R&D Pfizer Inc Cambridge MA USA

4. Discovery Science, Medicine Design Worldwide R&D Pfizer Inc Groton CT USA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12672

Reference51 articles.

1. The role of transporters in drug interactions

2. International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

3. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development

4. ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

5. Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Biomarker‐Informed Drug Interaction Evaluation in Drug Development and Regulatory Decision Making;Clinical Pharmacology & Therapeutics;2024-09-09

2. Brightening the Path: Riboflavin Illuminates Breast Cancer Resistance Protein Monitoring;Journal of Pharmacology and Experimental Therapeutics;2024-07-18

3. Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach;Clinical Pharmacology in Drug Development;2024-05-16

4. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

5. Clinical Analysis and <i>in Vitro</i> Correlation of BCRP-Mediated Drug–Drug Interaction in the Gastrointestinal Tract;Biological and Pharmaceutical Bulletin;2024-04-01